Full Access
A REVIEW OF MIXED CONNECTIVE TISSUE DISEASE
ANDREW CHUBICK M.D.,
JAMES N. GILLIAM M.D.,
ANDREW CHUBICK M.D.
From the Department of Internal Medicine, Divisions of Rheumatology and Dermatology, The University of Texas Southwestern Medical School, Dallas. Texas
Search for more papers by this authorCorresponding Author
JAMES N. GILLIAM M.D.
From the Department of Internal Medicine, Divisions of Rheumatology and Dermatology, The University of Texas Southwestern Medical School, Dallas. Texas
2 James N. Gilliam, M.D., Department of internal Medicine, The University of Texas Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, TX 75235.Search for more papers by this authorANDREW CHUBICK M.D.,
JAMES N. GILLIAM M.D.,
ANDREW CHUBICK M.D.
From the Department of Internal Medicine, Divisions of Rheumatology and Dermatology, The University of Texas Southwestern Medical School, Dallas. Texas
Search for more papers by this authorCorresponding Author
JAMES N. GILLIAM M.D.
From the Department of Internal Medicine, Divisions of Rheumatology and Dermatology, The University of Texas Southwestern Medical School, Dallas. Texas
2 James N. Gilliam, M.D., Department of internal Medicine, The University of Texas Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, TX 75235.Search for more papers by this author
References
- 1 Sharp, G. C., Irvin, W. C., Tan, E. M., Gould, R. G., and Holman, H. R.: Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am. J. Med. 52: 148, 1972.
- 2 Holman, H. R.: Partial purification and characterization of an extractable nuclear antigen which reacts with SLE sera. Ann. NY Acad. Sci. 124: 800, 1965.
- 3 Sharp, G. C., Irvin, W. S., LaRoque, R. L., Velez, C., Daly, V., Kaiser, A. D., and Holman, H. R.: Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy. J. Clin. Invest. 50: 350, 1971.
- 4 Hargraves, M. M., Richmond, H., and Morton, R.: Presentation of two bone marrow elements: the “Tart” cell and “LE” cell. Proc. Staff Meet. Mayo Clinic 23: 25, 1948.
- 5 Friou, G. J.: Clinical application of lupus serum—nucleoprotein reaction using fluorescent antibody technique. J. Clin. Invest. 36: 890, 1957.
- 6 Reichlin, M., and Mattioli, M.: Antigens and antibodies characteristic of systemic lupus erythematosus. Bull. Rheum. Dis. 24: 756, 1974.
- 7 Sturgill, B. C., and Carpenter, R. R.: Antibody to ribosomes in systemic lupus erythematosus. Arthritis Rheum. 8: 213, 1965.
- 8 Schur, P. H., Moroz, L. A., and Kunkel, H. G.: Precipitating antibodies to ribosomes in the serum of patients with systemic lupus erythematosus. Immunochemistry 4: 447, 1967.
- 9 Clark, G., Reichlin, M., and Tomasi, T. B.: Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J. Immunol. 102: 117, 1969.
- 10 Mattioli, M., and Reichlin, M.: Heterogeneity of RNA-protein antigens reactive with sera of patients with systemic lupus erythematosus: Description of cytoplasmic nonribosomal antigen. Arthritis Rheum. 17: 421, 1974.
- 11 Schur, P. H., and Monroe, M.: Antibodies to ribonucleicacid in systemic lupus erythematosus. Proc. Nat. Acad. Sci. 63: 1102, 1969.
- 12 Steinberg, A. D., Baron, S., and Talal, N.: The pathogenesis of autoimmunity in New Zealand mice. I. Induction of antinucleic acid antibodies by polyinosinic and polycytidylic acid. Proc. Nat. Acad. Sci. 63: 1102, 1969.
- 13 Schur, P. H., Stollar, D., Steinberg, A. D., et al.: Incidence of antibodies to double-stranded RNA in systemic lupus erythematosus and related diseases. Arthritis Rheum. 14: 342, 1971.
- 14 Talal, N., Steinberg, A. D., and Daley, G.: Inhibition of antibodies binding polyinosinic-polycytidylic acid in human and mouse lupus sera by viral and synthetic ribonucleic acids. J. Clin. Invest. 50: 1248, 1971.
- 15 Burnham, T. K., and Bank, P. W.: Antinuclear antibodies. I. Patterns of nuclear immunofluorescence. J. Invest. Dermatol. 62: 526, 1974.
- 16 Beck, J. S.: Variations in morphological patterns of “autoimmune” nuclear fluorescence. Lancet 1: 1203, 1961.
- 17 Burnham, T. K.: Antinuclear antibodies: II. The prognostic significance of nuclear immunofluorescent patterns in lupus erythematosus. Arch. Dermatol. 111: 203, 1975.
- 18 Tan, E. M.: Relationship of nuclear staining patterns with precipitating antibodies in systemic lupus erythematosus. J. Lab. Clin. Med. 70: 800, 1967.
- 19 Tan, E. M., and Kunkel, H. G.: Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J. Immunol. 96: 464, 1966.
- 20 Northway, J. D., and Tan, E. M.: Differentiation of antinuclear antibodies giving speckled staining patterns in immunofluorescence. Clin. Immunol. Immunopathol. 1: 140, 1972.
- 21 Rothfield, N. F., and Stollar, B. D.: The relationship of immunoglobulin class, pattern of antinuclear antibody and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus. J. Clin. Invest. 46: 1785, 1967.
- 22 Casals, S., Friou, G., and Teague, P.: Specific nuclear reaction pattern of antibody to DNA in lupus erythematosus sera. J. Lab. Clin. Med. 62: 625, 1963.
- 23 Casals, S. P., Friou, G. J., and Myers, L. L.: Significance of antibody to DNA in systemic lupus erythematosus. Arthritis Rheum. 7: 379, 1964.
- 24 Townes, A. S.: Immunologic studies of systemic lupus erythematosus. I. Quantitative estimations of nucleoprotein-reactive gamma globulin in systemic lupus erythematosus and other diseases. Bull. Johns Hopkins Hosp. 112: 183, 1963.
- 25 Robitaille, P., and Tan, E. M.: Relationship between deoxyribonucleoprotein and deoxyribonucleic acid antibodies in systemic lupus erythematosus. J. Clin. Invest. 52: 316, 1973.
- 26 Gonzales, E. N., and Rothfield, N. F.: Immunoglobulin class and pattern of nuclear fluorescence in systemic lupus erythematosus. N. Engl. J. Med. 274: 1333, 1966.
- 27 Burnham, T. K.: Antinuclear antibodies in lupus erythematosus. Arch. Dermatol. 112: 1329, 1976.
- 28 Hurd, E. R., Personal communication, 1976.
- 29 Cepellini, R., Polli, E., and Celeda, F.: DNA-reacting factor in serum of a patientwith lupus erythematosus diffusus. Proc. Soc. Exp. Biol. Med. 96: 572, 1957.
- 30 Deicher, H. R., Holman, H. R., and Kunkel, H. G.: The precipitin reaction between DNA and a serum factor in systemic lupus erythematosus. J. Exp. Med. 109: 97, 1959.
- 31 Robbins, W. C., Holman, H. R., Deicher, H., and Kunkel, H. G.: Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc. Soc. Exp. Biol. Med. 96: 575, 1957.
- 32 Seligman, M.: Evidence in the serum of patients with systemic lupus erythematosus of a substance producing a precipitation reaction with DNA. C. R. Soc. Biol. 245: 243, 1957.
- 33 Koffler, D., Carr, R. I., Agnello, V., Feizl, T., and Kunkel, H. G.: Antibodies to polynucleotides: distribution in human serums. Science 166: 1648, 1969.
- 34 Tan, M., and Epstein, W. V.: A solid-phase immunoassay for antibody to DNA and RNA. J. Lab. Clin. Med. 81: 122, 1973.
- 35 Notman, D. D., Kurata, N., and Tan, E. M.: Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann. Int. Med. 83: 464, 1975.
- 36 Tan, E. M., Schur, P. H., Carr, R. I., and Kunkel, H. G.: Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J. Clin. Invest. 45: 1732, 1966.
- 37 Koffler, D., Schur, P. H., and Kunkel, H. G.: Immunologic studies concerning the nephritis of systemic lupus erythematosus. J. Exp. Med. 126: 607, 1967.
- 38 Schur, P. H., and Sandson, J.: Immunologic factors and clinical activity in systemic lupus erythematosus. N. Engl. J. Med. 278: 533, 1968.
- 39 Krishnan, C., and Kaplan, M. H.: Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of γ globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis. J. Clin. Invest. 46: 569, 1967.
- 40 Cochrane, C. G., and Koffler, D.: Immune complex disease in experimental animals and man. Adv. Immunol. 16: 185, 1973.
- 41 Holman, H. R., Deicher, H. R. G., and Kunkel, H. G.: The LE cell and the LE serum factors. Bull. N.Y. Acad. Med. 35: 409, 1959.
- 42 Holman, H. R.: Partial purification and characterization of an extractable nuclear antigen which reacts with SLE sera. Ann. N.Y. Acad. Sci. 124: 800, 1965.
- 43 Mattioli, M., and Reichlin, M.: Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera. J. Immunol. 107: 1281, 1971.
- 44 Parker, M. D.: Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma and mixed connective tissue disease. J. Lab. Clin. Med. 82: 767, 1973.
- 45 Farber, S. J., and Bole, G. G.: Antibodies to components of extractable nuclear antigen: Clinical characteristics of patients. Arch. Int. Med. 136: 425, 1976.
- 46 Sharp, G. C.: Mixed connective tissue disease. Bull. Rheum. Dis. 25: 828, 1975.
- 47 Sharp, G. C., May, C., Irvin, W. S., Holman, H. R., McDuffie, F. C., Hess, E. V., and Schmid, F. R.: Clinical and laboratory characteristics of patients with antibodies to the ribonucleoprotein (RNP) component of extractable nuclear antigen (ENA). Arthritis Rheum. 16: 569, 1973.
- 48 Singsen, B., Kornreich, H., King, K., Bernstein, B., Hanson, V., and Tan, E.: Mixed connective tissue disease in children. Arthritis Rheum. 19: 822, 1976.
- 49 Baldassare, A., Weiss, T., Auclair, R., and Zuchner, J.: Mixed connective tissue disease in children. Arthritis Rheum. 19: 788, 1976.
- 50 Sharp, G. C.: Mixed connective tissue disease—overlap syndromes. Clin. Rheum. Dis. 1: 561, 1975.
- 51 Sharp, G. C., Irvin, W. S., May, C. M., Holman, H. R., McDuffie, F. C., Hess, E. V., and Schmid, F. R.: Association of autoantibodies to ribonucleoprotein and Smantigens with mixedconnective tissue disease (MCTD), systemic lupus erythematosus (SLE) and other rheumatic diseases. Clin. Res. 23: 50A, 1976.
- 52 Hench, P. K., Edgington, T. S., and Tan, E. M.: The evolving clinical spectrum of mixed connectivetissue disease. Arthritis Rheum. 17: 404, 1975.
- 53 Gilliam, J. N., and Prystowsky, S. D.: Mixed connective tissue disease syndrome: The cutaneous manifestations of patients with high titer serum antibody to RNase sensitive extractable nuclear antigen (ENA). Arch. Dermatol. In press.
- 54 Reichlin, M., and Mattioli, M.: Correlation of a precipitin reaction to an RNA protein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. Engl. J. Med. 286: 908, 1972.
- 55 Harmon, C., Wolfe, J. F., Lillard, S., Held, C., Cordan, R., and Sharp, G. C.: Pulmonary involvement in mixed connective tissue disease. Arthritis Rheum. 19: 801, 1976.
- 56 Gilliam, J. N.: The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZB/NZW FI hybrid mice. J. Invest. Dermatol. 65: 154, 1975.
- 57 Cohen, A.S., Reynolds, W. E., Franklin, E.C., Kuller, J. P., Ropes, M. W., Shulman, L. E., and Wallace, S. L.: Preliminary criteria for the classification of systemic lupus erythematosus. Bull. Rheum. Dis. 21: 643, 1971.
Citing Literature
